In AD-transgenic mice, brain-derived neurotrophic factor (BDNF), when administered after disease onset, can reverse synapse loss, partially normalize aberrant gene expression, improve cell signaling, and restore learning and memory [17, 18]. This evidence concerns the gene BDNF and Alzheimer disease.